Affimed

YTD

ALL

Why Robinhood?

You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Shawn M. Leland, PharmD

CEOShawn M. Leland, PharmD

Employees

—

Employees—

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

—

Employees—

AFMD Key Statistics

Market cap

96.88M

Market cap96.88M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

97.87M

Average volume97.87M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$8.95

52 Week high$8.95

52 Week low

$0.018

52 Week low$0.018

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.